Differential effects of neonatal SSRI treatments on hypoxia-induced behavioral changes in male and female offspring. (30th September 2017)
- Record Type:
- Journal Article
- Title:
- Differential effects of neonatal SSRI treatments on hypoxia-induced behavioral changes in male and female offspring. (30th September 2017)
- Main Title:
- Differential effects of neonatal SSRI treatments on hypoxia-induced behavioral changes in male and female offspring
- Authors:
- Nagano, Reiko
Nagano, Masatoshi
Nakai, Akihito
Takeshita, Toshiyuki
Suzuki, Hidenori - Abstract:
- Highlights: Prenatal hypoxia produced differential behavioral changes in male and female offspring. Neonatal fluoxetine, an SSRI, ameliorated the behavioral changes in both males and females. Neonatal escitalopram, an SSRI, ameliorated the behavioral changes only in females. Both SSRIs suppressed the increase in dopamine levels induced by prenatal hypoxia in the female hippocampus. Abstract: Prenatal hypoxia induced by transient intrauterine ischemia is a serious clinical problem, and at present, effective treatments are lacking. Currently, it is unknown how prenatal hypoxia affects behaviors in adulthood. Therefore, we developed a mouse model that mimics prenatal hypoxia in humans using uterine artery occlusion in late gestation. We examined whether prenatal hypoxia induces behavioral changes in adult male and female offspring by conducting a series of behavioral tests. In adulthood, longer immobility was observed in the forced swim test in males, whereas females showed decreased inhibition in the prepulse inhibition test. We then investigated the effects of two different selective serotonin reuptake inhibitors (SSRIs), fluoxetine (FLX) and escitalopram (ESC), on these behavioral changes. These drugs affect the neurodevelopmental process and have long-term neurological consequences. FLX treatment from postnatal day 3 (P3) to P21 ameliorated the behavioral changes in both male and female mice. In comparison, ESC treatment ameliorated the behavioral changes only in femaleHighlights: Prenatal hypoxia produced differential behavioral changes in male and female offspring. Neonatal fluoxetine, an SSRI, ameliorated the behavioral changes in both males and females. Neonatal escitalopram, an SSRI, ameliorated the behavioral changes only in females. Both SSRIs suppressed the increase in dopamine levels induced by prenatal hypoxia in the female hippocampus. Abstract: Prenatal hypoxia induced by transient intrauterine ischemia is a serious clinical problem, and at present, effective treatments are lacking. Currently, it is unknown how prenatal hypoxia affects behaviors in adulthood. Therefore, we developed a mouse model that mimics prenatal hypoxia in humans using uterine artery occlusion in late gestation. We examined whether prenatal hypoxia induces behavioral changes in adult male and female offspring by conducting a series of behavioral tests. In adulthood, longer immobility was observed in the forced swim test in males, whereas females showed decreased inhibition in the prepulse inhibition test. We then investigated the effects of two different selective serotonin reuptake inhibitors (SSRIs), fluoxetine (FLX) and escitalopram (ESC), on these behavioral changes. These drugs affect the neurodevelopmental process and have long-term neurological consequences. FLX treatment from postnatal day 3 (P3) to P21 ameliorated the behavioral changes in both male and female mice. In comparison, ESC treatment ameliorated the behavioral changes only in female mice. Neurochemical analysis revealed that dopamine was increased in the female hippocampus, but not in males. Thus, neonatal SSRI treatment decreases dopamine levels in the hippocampus in females selectively. Our findings suggest that prenatal hypoxia is a risk factor for behavioral abnormalities in adulthood, and that neonatal SSRI treatment might have clinical potential for alleviating these long-term behavioral deficits. … (more)
- Is Part Of:
- Neuroscience. Volume 360(2017)
- Journal:
- Neuroscience
- Issue:
- Volume 360(2017)
- Issue Display:
- Volume 360, Issue 2017 (2017)
- Year:
- 2017
- Volume:
- 360
- Issue:
- 2017
- Issue Sort Value:
- 2017-0360-2017-0000
- Page Start:
- 95
- Page End:
- 105
- Publication Date:
- 2017-09-30
- Subjects:
- 5-HIAA 5-hydroxyindole acetic acid -- CS conditioned stimulus -- DA dopamine -- DAT dopamine transporter -- DOPAC 3, 4-dihydroxy-phenylacetic acid -- EPM elevated plus maze -- ESC escitalopram -- FLX fluoxetine -- FST forced swim test -- GD gestational day -- HPLC high-performance liquid chromatography -- NET norepinephrine transporter -- OF open field test -- PFC prefrontal cortex -- PPI prepulse inhibition test -- SERT serotonin transporter -- SSRI selective serotonin reuptake inhibitor -- UAO uterine artery occlusion -- US unconditioned stimulus
prenatal hypoxia -- behavior -- intervention -- serotonin -- dopamine
Neurochemistry -- Periodicals
Neurophysiology -- Periodicals
Neurology -- Periodicals
Neurochimie -- Périodiques
Neurophysiologie -- Périodiques
Neurochemistry
Neurophysiology
Electronic journals
Periodicals
Electronic journals
612.8 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03064522 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/03064522 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/03064522 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.neuroscience.2017.07.051 ↗
- Languages:
- English
- ISSNs:
- 0306-4522
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.559000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4659.xml